How our research benefits to society
This study offers patients who are desperately in need of new treatment options, the opportunity to try esketamine as an antidepressant. Through joint data collection in three treatment centers, the effectiveness, side effects and predictive value of different clinical characteristics can be investigated in a relatively large sample. Furthermore, the patients who enter the longer term maintenance phase are monitored until cessation of the esketamine treatment. This allows research regarding longer term side effects on cognition, live rand kidneys or the development of tolerance.